Tirzepatide

CAS No.: 2023788-19-2

Tirzepatide Chemical Structure

Molecular formula : C₂₂₅H₃₄₈N₄₈O₆₈
Molecular weight : 4813.45
Dositive specifications : 2.5mg,5mg,7.5mg,10mg,15mg/0.5ml
Injection : 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, or 15 mg / 0.5 mL in single-dose pen

Biological Activity

Tirzepatide causes thyroid C-cell tumors in rats. It is unknown whether MOUNJARO causes thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans as the human relevance of tirzepatide-induced rodent thyroid C-cell tumors has not been determined .

MOUNJARO

Chemical Properties

ACTIONS	—
CAS NO.	2023788-19-2
FORMULA	C₂₂₅H₃₄₈N₄₈O₆₈
M.WT	4813.45
PURITY	>98%
SYNONYMS	GIPGLP-1
STORAGE	—

Online Inquiry

Diabetes

Chinese diabetic people may have a total of 143 million people, accounting for 23%of the global patients with diabetes. It is the country with the most diabetic patients in the world. Among them, type II diabetes account for about 90%of the number of diabetes, and type I diabetes and gestational diabetes account for about 9 ~ 10%.

Other Drug Peptide

Terzapitide NEW

Semaglutide NEW

Semaglutide causes thyroid C-cell tumors. It is unknown whether OZEMPIC causes thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans, as the human relevance of semaglutide-induced rodent thyroid C-cell tumors has not been determined.

Retatrutide NEW

Retatrutide (LY3437943) is a triple agonist peptide of glucagon receptor (GCGR), glucose-dependent insulin- promoting peptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R), developed for the treatment of obesity and related metabolic disorders.

Cagrilintide NEW

Cagrilintide is an investigational novel long-acting acylated amylin analogue, acting as a nonselective amylin receptor (AMYR) and calcitonin G protein-coupled receptor (CTR) agonist. Cagrilintide induces significant weight loss and reduces food intake.

Linaclotide NEW

Linaclotide is a potent and selective guanylate cyclase C agonist, developed for the treatment of constipation-type irritable bowel syndrome (IBS-C) and chronic constipation.

BESTBELL